Why the study?
Does the visceral adiposity index predict clinical severity and therapeutic outcome in women with PCOS?
Population
Women with Polycystic ovary syndrome (PCOS)
Design
Review
Authors
Loading...
Assessment of visceral adiposity may refine CV risk stratification in PCOS; leaves open whether targeted reduction improves outcomes.
Does the visceral adiposity index predict clinical severity and therapeutic outcome in women with PCOS?
Visceral adiposity index (VAI) may serve as a useful clinical tool to predict disease severity and therapeutic outcomes in women with PCOS.
Zheng et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: